Previous close | 0.2500 |
Open | 0.2600 |
Bid | 0.0000 x N/A |
Ask | 0.2650 x N/A |
Day's range | 0.2500 - 0.2650 |
52-week range | 0.2300 - 1.0500 |
Volume | |
Avg. volume | 115,741 |
Market cap | N/A |
Beta (5Y monthly) | 0.96 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1980 |
Earnings date | 29 July 2024 - 02 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
With the launch of a new website dedicated to their global clinical trials (https://hope4OA.com), Paradigm Biopharmaceuticals Ltd. (Paradigm Biopharma) aims to provide relief to millions of osteoarthritis (OA) sufferers worldwide by developing a new injectable drug.